It is now widely recognised that the biological behaviour of tumours, which may differ markedly for neoplasms of similar histopathological category and grade, is determined to a significant extent by interactions with neighbouring cells and by their environment in general. Attempts to unravel the critical factors in these complex in vivo interactions have, in part, focussed on the relationship between leucocyte infiltration and prognosis, for which, there exists, at least for some neoplasms, a positive correlation (Underwood, 1974; loachim, 1976) as well as upon the anti-tumour properties in vitro of inflammatory cells recovered from disaggregated neoplasms (see Haskill, 1982; Vose & Moore, 1985) .
In the study of human tumours, only a limited examination of the many parameters involved in leucocyte ingress is presently feasible mainly because the antigens expressed by these neoplasms have only been partially defined. Of theoretical relevance to host recognition of tumour cells in this context, is the expression of products of the major Correspondence: M. Moore. Received 15 April 1985; and in revised form, 9 July 1985. histocompatibility complex (MHC). Class I (HLA-A, B, C) antigens are found on virtually all normal epithelial cells, and their recognition is essential for the killing of virus-infected target cells (McMichael, 1978) by cytotoxic T lymphocytes and possibly of tumour cells also. MHC Class II products were until recently, considered to be restricted to cells of the immune system, including B lymphocytes, macrophages, vascular endothelial, dendritic and other antigen presenting cells, as well as activated T lymphocytes (Ko et al., 1979) . Now in addition, certain epithelia and a significant number of nonlymphoid neoplasms including those of breast, colorectal carcinoma and malignant melanoma are known to display Class II molecules (Natali et al., 1981; Thompson et al., 1982; Whitwell et al., 1984; Daar & Fabre, 1983; Rognum et al., 1983) . Currently there is interest in whether this property is a requirement for the induction of autologous lymphoproliferative responses by tumour antigens of the MHC status of tumour cells and the in situ host response in a manner which has hitherto proved impossible using conventional histological techniques. In this study we extend this approach, previously applied in this laboratory to breast and colorectal carcinomas (Whitewell et al., 1984; Csiba et al., 1984) (Whitwell et al., 1984) . Briefly, sections were incubated in the monoclonal antibody (McAb) (Whitwell et al., 1984) . In most instances, morphometric analyses were precluded by the intra-tissue variation across a given section.
Monoclonal antibodies (McAbs)
With the exception of the B73.1 reagent, details of the McAbs used in this study have been given previously (Whitwell et al., 1984; Csiba et al., 1984) and are summarised in Table I Normal cervix MHC Class I antigens were strongly expressed on the lower one-third to one half of the squamous epithelium (Figure 3) . In 10/14 samples endocervical glands were present, which were Class I positive. There was no obvious correlation with the hormonal status of the women. MHC Class II antigens were indetectable on epithelial cells but almost all tissues revealed a few DR + leucocytes scattered at the base of the squamous epithelium and around the squamocolumnar junction and endocervical glands. Seven of 10 samples which contained endocervical glands exhibited Class II staining of the glandular cells which was again apparently unrelated to the hormonal status of the women.
2D1 + leucocytes were present in moderate numbers in 13/13 specimens. They were most numerous at the base of the squamous epithelium at the squamo-columnar junction and around endocervical glands. They were also found scattered throughout the lower half of the squamous epithelium. Most of the 2D1 + populations were also UCHTI+ indicating a predominance of T cells (Figure 4) but not to the exclusion of other cell types. OKT8 + cells were more consistently demonstrable (12/12 tissues) and numerically superior to OKT4 cells (detected in 8/13 tissues). Eleven of 12 tissues contained MAS020+ cells, albeit in low numbers around endocervical glands which in most instances were also stained with this reagent. OKM 1+ cells were equally sparsely represented in 9/14 tissues, with a slight excess at the squamo-columnar junction. Cervical carcinoma (Table III) stroma in 8/10 specimens (in relatively large numbers in five of these). In two cases this reagent also stained the tumour cells. Nine of 10 samples contained substantial numbers of OKM 1 cells mostly confined to the stroma but sometimes in close juxtaposition to tumour cells ( Figure 6 ). Staining with OKM 1 was also marked at the necrotic centre of three neoplasms.
Normal endometrium Cells comprising the endometrial glands, myometrial tissue, endothelium and the stromal component of the endometrium were uniformly 2A1 + and in 6/13 cases the endometrial glands were also Class II positive. This latter property was not related to the hormonal status of the patients. 2D 1+ leucocytes were present in moderate numbers in all 13 tissues examined, a small proportion of which were DR+. These were more numerous in the endometrium than in the underlying myometrium and tended to cluster around the endometrial glands. The leucocytes consisted predominantly of T cells of which OKT8+ cells were more consistently detected (12/12 cases) than OKT4+ cells (9/13 cases). Ten of 12 specimens contained low numbers of B cells and there were also few OKM 1 cells. Some normal endometrial glands were stained with Leu 7 (HNKI) and MAS020. There was little apparent quantitative variation in the number and subtype of leucocytes during the varying phases of the menstrual cycle.
Endometrial carcinoma (Table IV) cases. There was no correlation between antigen expression and tumour grade. Only 2/8 tumours (patients BC and FH) expressed DR antigens on the epithelial cells (cf. Figure 7) ; these tumours were well differentiated and the pattern of staining was heterogeneous.
2D1 + cells were present in large numbers in all 8 tumours examined. These were especially numerous at the junctional areas between tumour and normal tissue and in the tumour stroma. Five samples showed significant penetration of the tumour mass.
Most of the 2D1 + leucocytes were T cells. Again, in 4/8 samples OKT8 + cells were numerically superior to OKT4+ cells. In this series, lymphocytes which had penetrated the tumour mass were predominantly of OKT8 phenotype (Figure 8 ) and DR' leucocytes which comprised macrophages as well as lymphocytes (Figure 9 ). B cells were also represented in moderate numbers in the stroma, but were exceeded by cells of OKM1 + phenotype, which were also detectable in the tumour mass (5/8 cases). In 4 of the 8 neoplasms, apparent crossreactivity with MAS020 of the most differentiated tumour cells was in evidence. In addition, some fibrous septal areas between endometrial tumour masses were stained with Leu 7 (HNK1).
Discussion
While several tumour-associated antigens of gynaecological neoplasms have been detected serologically Bhattacharya et al., 1982; Masuho et al., 1984) their ability to evoke immune responses in the autochthonous host is unknown. Accordingly, attention was focussed on the MHC products of tumour cells which are likely to be involved in immune induction and tumour cell recognition and the nature of the in situ inflammatory cells as defined by monoclonal antibodies. In respect of these properties this study has disclosed a number of potentially important differences between malignant gynaecological tumours and their normal tissue counterparts. It is preliminary to the extent that the panel of McAbs was limited as were the numbers of tumours examined of each of the major types. Malignant epithelial cells were frequently MHC Class I negative, under conditions where the stroma was strongly positive. The difference from normal tissue was most marked in the case of cervical and ovarian carcinoma where the majority of tutmours were negative. A trend towards Class I negativity among endometrioid ovarian neoplasms was reported by Kabawat et al. (1983) . Our failure to encounter Class I positive tumours in our smaller series is thus probably a reflection of the predominance of these histological types rather than of differential staining sensitivity. To our knowledge, the HLA Class I status of cervix and endometrial carcinomas and their normal tissue counterparts has not been previously reported (cf. Daar et al., 1984a) . Depressed or heterogeneous expression of MHC Class I products, as detected by immunohistological procedures, is a property of some tumours of diverse histogenic derivation including breast (Fleming et al., 1981; Bhan & Des Marais, 1983; Rowe & Beverley, 1984; Whitwell et al., 1984) and to a lesser extent, colorectal carcinoma (Csiba et al., 1984) . Other neoplasms, notably malignant melanoma (Ruiter et al., 1982) and certain histological categories of ovarian carcinoma (Kabawat et al., 1983) appear to express Class I antigens with greater consistency, a phenomenon which is apparently related to the predominantly T cell infiltrate which is a feature of these tumours.
The level of the failure of primary tumours to express Class I antigens has yet to be elucidated. The immunoperoxidase method as employed in this study is essentially a qualitative technique, so that levels of Class I expression below the threshold limits of detection, could conceivably occur, i.e. the deficit may be relative, rather than absolute.
As exemplified by genetic experiments with Daudi cells (Arce-Gomez et al., 1978) some tumours may fail to express HLA due to lack of /2 microglobulin (/2 i), the low molecular weight glycoprotein required to stablize the Class I heavy chain. (De Vries & Spits, 1984) . Thus, it may not be without significance in our study that OKT8 + cell influx was not correlated with HLA Class I status.
It is also possible that lack of Class I determinants influences cell:cell interactions outside the immune system in a way, e.g. that favours the emergence of metastatic variants.
In common with other tissues, MHC Class II molecules, normally considered to be confined to cells of the immune system were frequently detectable on the glandular epithelia of normal cervix and endometrium (cf. Daar et al., 1984b) . The so-called 'aberrant expression' of Class II products on normal epithelial cells is associated with immunological, inflammatory as well as hormonal stimuli (Klareskog et al., 1980; Lampert et al., 1981; Mason et al., 1981; Selby et al., 1983) and similar stimuli could promote their expression on malignant epithelial cells.
In cervical and endometrial tumours MHC Class II expression appears to reflect the cellular origin of the neoplasm. On the other hand, tumours originating from apparently DR-negative epithelium (ovary) could acquire the ability to express Class II molecules in response to stimuli of the type mentioned above.
In both autoimmune and neoplastic diseases MHC Class II products on target cells are envisaged as a vehicle for the presentation of autoantigen to T helper/inducer lymphocytes on the assumption that the configuration of the particular Class II product fits that of the autoantigen (Londei et al., 1984) . In malignant melanoma, for instance, autologous lymphoproliferative responses can be induced by DR-positive tumour cells (Guerry et al., 1984) (Ortaldo et al., 1981) , the LGL population was monitored in sections with two McAbs, one of which (B73.1) is reactive with virtually the entire LGL population (Perussia et al., 1983a,b) and another (Leu 7; HNK1) which reacts with approximately 75% of LGL as well as a subset of T (suppressor) cells (Abo & Balch, 1981; Abo et al., 1982a,b) . B73.1+ or Leu 7+ cells were scarcely ever seen, indicating that the OKM1 + population was probably wholly of monocyte/macrophage composition. In ovarian cancer, there is marked size variation and cytochemical heterogeneity among macrophages which is associated with a spectrum of activities from suppression to antibody-dependent cellular cytotoxicity (Haskill et al., 1982b) . However, gynaecological cancers, like those of breast, colon and lung (Watanabe et al., 1983; Bhan & Des Marais, 1983; Whitwell et al., 1984; Csiba et al., 1984) , contain few cells of natural killer phenotype.
This conclusion is in concordance with earlier functional and morphological data on a variety of tumours from several laboratories (Moore & Vose, 1981; Eremin et al., 1981; Pizzolo et al., 1984) and on ovarian cancer, in particular (Introna et al., 1983; Kabawat et al., 1983) . The implications are that NK cells, which are maximally expressed in blood and spleen rarely extravasate and any direct anti-tumour activity is consequently very limited or non-existent.
The stimuli to leucocyte ingress into solid neoplasms are still largely unknown though the presumption remains that tumour antigenicity is a major, but certainly not the only factor. Whether human gynaecological neoplasms are immunogenic in the autologous host or not, the demonstration that the extravasation of leucocytes is not a random event might be relevant to host reponses of an immune nature. Although niopliometric analysis of infiltrating populations is often complicated by marked heterogeneity in a given section, it is clear that some populations predominate over others. In many sections, there was little doubt that T8+ cells exceeded T4+ cells, indicative of a shift from the proportions normally present in peripheral blood, though perhaps to a lesser extent from those in patients with progressive or advanced disease (cf. McCluskey et al., 1983) . Similarly as already noted, in cervical carcinoma there was a significant ingress of B cells which was not consistent with random extravasation. However, it is possible that in certain carcinomas (e.g. endometrial), the association of T8 + lymphocytes with epithelial cells is not indicative of a reaction to the tumour at all, but is rather a reflection of the normal relationship between the lymphocytes and epithelial cells in this tissue.
Functional studies showing depressed proliferative activity in T cells recovered from ovarian cancers implicated tumour inactivation as the cause, or failure of a particular subset to localise at the tumour site (Haskill et al., 1982a ). An alternative explanation might be that the predominant T8 + subset contains functionally active suppressor cells (Vose & Moore, 1979) . This possibility, which would theoretically favour tumour growth, might not be entirely unexpected in tumours which, apart from therapeutic intervention, have 'escaped' beyond recall as would doubtless have been the case for the tumours in this study. At this point, late in the progression of the lesions, the magnitude and type of cellular immune response is likely to have little in vivo operational significance to the advantage of the host.
